An off-the-shelf stem cell therapy for type 1 diabetes continues to show positive results, according to a new study.

Results for weight-loss drug targeting amylin find similar efficacy across different doses and high rates of side effects, ...

The ouster of the FDA's chief regulator of cell and gene therapies came immediately after a disagreement with her boss over a ...

Being cited in a major government report, like the MAHA report on children’s health, should be gratifying. Not this time.

To prevent ovarian cancers, fallopian tube removal is on an upsurge — and diagnostic manuals are finally catching up.

As the market for AI enabled medical devices grows, experts say there is less transparency around device approvals.

Gilead's CEO says he's committed to making sure people around the world can get his firm's new HIV prevention shot Yeztugo.

We are witnessing a dismantling of the systems that develop, license, recommend, and monitor vaccines,” write six former ...

We look at the continued turmoil within the FDA, including the forced dismissal of top gene therapy regulator Nicole Verdun, ...

That is according to the findings of a study presented on Friday at the European Academy of Neurology congress. The pilot ...

A new twice-yearly shot could be a "game changer" in the fight against AIDS, but experts' hopes have dimmed because of the ...

And more pharma news updates from Pharmalittle.